Source of increased plasminogen activators during pregnancy and puerperium. 1989

H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
Department of Obstetrics and Gynecology, Kobe Central Municipal Hospital, Japan.

We investigated the increase of plasminogen activators (tPA and uPA) in the plasma during pregnancy. Both tPA and uPA antigens were found to increase after the third trimester of pregnancy and high levels of PAs persisted through the first stage of labor. The tPA antigen levels rose further for the first few hours post-partum, while the level of uPA antigen returned to normal immediately following childbirth. To clarify whether the uterus and/or placenta are involved in the increased levels of plasma PAs, the levels were measured in uterine venous blood in cases of caesarean sections. During the ante-partum period, the level of uPA antigen in the uterine venous blood was higher than that in the peripheral venous blood, while there was no significant difference between the levels of tPA antigen in peripheral blood and uterine venous blood. The level of tPA antigen in the uterine venous blood rose after delivery. In contrast, the level of uPA antigen declined immediately after delivery. These results suggest that (1) the placenta is the major source of the increased uPA antigen during pregnancy, (2) entire vascular system is involved in the increased tPA antigen during pregnancy, (3) a further increase in tPA after delivery is due to the release of this enzyme from the involuting uterus.

UI MeSH Term Description Entries
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011261 Pregnancy Trimester, First The beginning third of a human PREGNANCY, from the first day of the last normal menstrual period (MENSTRUATION) through the completion of 14 weeks (98 days) of gestation. Early Placental Phase,Pregnancy, First Trimester,Trimester, First,Early Placental Phases,First Pregnancy Trimester,First Pregnancy Trimesters,First Trimester,First Trimester Pregnancies,First Trimester Pregnancy,First Trimesters,Phase, Early Placental,Phases, Early Placental,Placental Phase, Early,Placental Phases, Early,Pregnancies, First Trimester,Pregnancy Trimesters, First,Trimesters, First
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator

Related Publications

H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
July 1984, The Biochemical journal,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
October 1990, Thrombosis and haemostasis,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
October 1965, Lancet (London, England),
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
January 1985, Folia psychiatrica et neurologica japonica,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
January 2006, European journal of obstetrics, gynecology, and reproductive biology,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
November 1996, Clinica chimica acta; international journal of clinical chemistry,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
July 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
January 1957, Gynecologie et obstetrique,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
June 1960, Revista de ginecologia e d'obstetricia,
H Shimada, and E Takashima, and M Soma, and M Murakami, and Y Maeda, and S Kasakura, and A Takada, and Y Takada
January 1970, Duodecim; laaketieteellinen aikakauskirja,
Copied contents to your clipboard!